drugmanrx
11 hours ago
ROFLMAO! You are not really that dumb are you?
Different company was occupying the the ticker then the one that is occupying the ticker TODAY.
What happen that company that company couldn't make it, so they tried to reverse merge with another
8k
Item 5.02 Departure of Directors or Certain Officers;
On December 23, 2022, the Company effected an action whereby the previous change of control was rescinded, and the parties were returned to as they were on October 30, 2022. In accordance with the action Alexander Woods-Leo resigned as director and from all offices of the Company and Jason Black was reinstated as Director, President, CEO, Secretary, and Treasurer of the Company.
8K
Item 5.02 Departure of Directors or Certain Officers;
On October 31, 2022, Jason Black resigned as a director and officer of the Company. Mr. Black's departure was not due to any dispute with the Company.
On October 31, 2022, Alexander Woods-Leo was appointed as director, President, CEO and Secretary of the Company. Mr. Alexander Woods-Leo is a published developer and patent holder with over a decade of experience with public companies and financial services.
When Leo could come up with the money, Blacke canceled the reverse merger then reversed merged with Tucker and Prodigy.
8k
On February 1, 2023, Jason Black resigned as director and from all offices of the Company. In consideration of severance to Mr. Black the Company divested its remaining subsidiary, Cannequipt LLC, and assigned its sole control to Mr. Black. The Company also assigned its loan agreements in "Cannagram" to Mr. Black. The Company has retained all ownership and rights to the "C-Juice" lines of CBD and Delta 8 products. The Company has also retained its hemp farming lease agreement in Glencoe, Oklahoma.
Item 1.01 Entry into a Material Definitive Agreement.
On January 30, 2023, the Company entered into a Binding Letter of Intent to acquire Prodigy Stem Cell, LLC as a wholly owned subsidiary of the Company.
8k Item 2.01 Completion of Acquisition or Disposition of Assets.
On March 1, 2023, the Company completed the acquisition of Prodigy Stem Cell, LLC as a wholly owned subsidiary. Prodigy Stem Cell, LLC is a New Jersey based company focused on sales, marketing, and consulting for regenerative medicines.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 1, 2023, the Company appointed Peter Caruso as a Director of the Company. Mr. Caruso has over 20 years of business development experience and is the Founder of Prodigy Stem Cell, LLC.
SMH
Hi_Lo
14 hours ago
Most recent CNNA quarterly financial statement from 2022:
https://www.otcmarkets.com/file/company/financial-report/348802/content
What happened to this?:
On December 10, 2021, the Company announced the launch of its signature vape cartridge line, C-Juice, a proprietary Delta 8 THC hemp extract that can be
legally consumed in most US states. It is offered in multiple flavors, and will be initially made available in retail outlets in Oklahoma, Kansas and Texas,
eventually branching out into additional markets including online sales.
There was no revenue in the financials concerning this.
On January 3, 2022, the Company announced the retention of a PCAOB auditor, Michael Gillespie & Associates, PLLC, to prepare for full SEC reporting and
an uplisting of the Company's stock.
That was four years ago and still nothing. It's still not SEC reporting, it's still in Expert Market and "uplisting" was a pipe dream.
The Company has a limited operating history and had a cumulative net loss from inception to August 31, 2022 of $8,638,484. The Company has a working
capital deficit of $3,183,521 as at August 31, 2022.
OUCH!!!
Again, what ever happened to this?:
On June 15, 2022, the Company announced it had entered into a lease agreement to develop a 10,000 square feet hemp farming operation in Glencoe,
Oklahoma, allowing the Company to vertically integrate the expansion of its recently-launched "C-Juice" vape lines. It will be managed by the Company's
director, Brad Hangar.
Again, mentioned once and never again. And again, there was no revenue in the financials concerning this and "C-Juice."
You can thank Motor-Goator for encouraging me to dig deeper into this scam company.
Hi_Lo
14 hours ago
https://www.securitieslawyer101.com/2023/shell-hijacker-mark-miller-sentenced-to-one-year-in-prison/
Public records show that Capitol Capital Corporation has also been involved as a noteholder in at least three other public issuers that used Jason Black as the CEO, MedX Holdings Inc (MEDH), Cann American Corp (CNNA), and Seven Arts Entertainment, Inc (SAPX).
CNNA recently appointed Jason Tucker, former CEO of LEAS, as its new CEO, giving it yet another connection to past Miller frauds. And according to SAPX OTC disclosures, on December 27, 2022, all the debt notes previously put in the name of Capitol Capital Corporation were transferred to an entity named Via Capital, represented in the SAPX filings by Jesus Cipriano, keeping the notes active despite Mark Miller’s various legal issues. Via Capital immediately started converting the debt into large chunks of free trading stock, including 150,000,000 shares on December 28, 2022, 150,000,000 shares on February 21, 2023, and 180,000,000 shares on March 6, 2023. SAPX has also begun to issue new debt notes to Via Capital.
Hi_Lo
14 hours ago
https://www.securitieslawyer101.com/2023/shell-hijacker-mark-miller-sentenced-to-one-year-in-prison/
On May 18, 2023, Mark Miller became the last of three men to be sentenced for a securities fraud scheme that involved hijacking several abandoned penny stocks, then using them for an illegal pump-and-dump stock manipulation scheme. Miller pleaded guilty to count 1 of the Indictment, Conspiracy to Commit Securities Fraud, and was sentenced to 12 months and 1 day in prison, followed by 2 years of supervised release...
CNNA recently appointed Jason Tucker, former CEO of LEAS, as its new CEO, giving it yet another connection to past Miller frauds. And according to SAPX OTC disclosures, on December 27, 2022, all the debt notes previously put in the name of Capitol Capital Corporation were transferred to an entity named Via Capital, represented in the SAPX filings by Jesus Cipriano, keeping the notes active despite Mark Miller’s various legal issues. Via Capital immediately started converting the debt into large chunks of free trading stock, including 150,000,000 shares on December 28, 2022, 150,000,000 shares on February 21, 2023, and 180,000,000 shares on March 6, 2023. SAPX has also begun to issue new debt notes to Via Capital.
Hi_Lo
14 hours ago
Jason Black CNNA & SAPX CEO
Straight from the SEC website:
https://www.sec.gov/enforcement-litigation/litigation-releases/lr-25469
Rahim Mohamed, Davies (Dave") Wong
SEC Charges 18 Defendants in International Scheme to Manipulate Stocks Using Hacked US Brokerage Accounts
Litigation Release No. 25469 / August 16, 2022
Securities and Exchange Commission v. Rahim Mohamed, Davies ("Dave") Wong, Glenn B. Laken, Richard C.S. Tang, Zoltan Nagy, Jeffrey D. Cox, Phillip G. Sewell, Breanne M. Wong, Christophe Merani, Anna Tang, Robert W. Seeley, Richard B. Smith, Christopher R. Smith, H.E. Capital SA, POP Holdings Ltd., Maximum Ventures Holdings LLC, Harmony Ridge Corp., and Avatele Group LLC, Defendants, and 9224-3708 Quebec, Inc., a/k/a Distributions Bano, and Jason Black, Relief Defendants, No. 1:22-cv-03252 (N.D. Ga. filed Aug. 15, 2022)
The Securities and Exchange Commission today charged 18 individuals and entities for their roles in a fraudulent scheme in which dozens of online retail brokerage accounts were hacked and improperly used to purchase microcap stocks to manipulate the price and trading volume of those stocks. Those charged include Rahim Mohamed of Alberta, Canada, who is alleged to have coordinated the hacking attacks, and several others in and outside the U.S. who allegedly benefited from or participated in the scheme.
According to the SEC's complaint, in late 2017 and early 2018, hackers accessed at least 31 U.S. retail brokerage accounts and used them to purchase the securities of Lotus Bio-Technology Development Corp. and Good Gaming, Inc. The unauthorized purchases allegedly enabled fraudsters, who already controlled large blocks of Lotus Bio-Tech and Good Gaming stock, to sell their holdings at artificially high prices and reap more than $1 million in illicit proceeds. According to the complaint, Davies Wong of British Columbia, Canada, and Glenn B. Laken of Illinois, respectively, controlled the majority of the Lotus Bio-Tech and Good Gaming stock that was sold while the hacking attacks were being carried out, and Mohamed coordinated with Davies Wong, Laken, and others to orchestrate the attacks. The complaint also alleges that Richard Tang of British Columbia, Canada, was involved with both the Lotus Bio-Tech and Good Gaming schemes.
The SEC's complaint charges violations of the antifraud and beneficial ownership reporting provisions of the Securities Act of 1933 ("Securities Act") and the Securities Exchange Act of 1934 ("Exchange Act"), and names two relief defendants who received proceeds from the hacks. More specifically, the complaint charges the following defendants with the following violations:
• Rahim Mohamed of Alberta, Canada, with directly violating, and aiding and abetting violations of, Section 17(a) of the Securities Act, and Sections 9(a) and 10(b) of the Exchange Act, and Rule 10b-5 thereunder;
Â
• Davies Wong of British Columbia, Canada, Richard Tang of British Columbia, Canada, Zoltan Nagy of British Columbia, Canada, Anna Tang of British Columbia, Canada, and Breanne Wong of British Columbia, Canada and Panama, with directly violating, and aiding and abetting violations of, Section 17(a) of the Securities Act, and Section 10(b) of the Exchange Act, and Rule 10b-5 thereunder, and directly violating Sections 13(d) and 16(a) of the Exchange Act, and Rules 13d-1 and 16a-3 thereunder;
Â
• Glenn B. Laken of Illinois, Jeffrey Cox of Alberta, Canada, Christophe Merani of Illinois, and Phillip Sewell of British Columbia, Canada, with directly violating, and aiding and abetting violations of, Section 17(a) of the Securities Act, and Section 10(b) of the Exchange Act, and Rule 10b-5 thereunder;
Â
• Robert Seeley of the Dominican Republic, Christopher R. Smith of the Dominican Republic, Richard B. Smith of the Dominican Republic, Wyoming entity Harmony Ridge Corp., and Nevis entities H.E. Capital SA and POP Holdings Ltd., with aiding and abetting violations of Section 17(a) of the Securities Act, and Section 10(b) of the Exchange Act, and Rule 10b-5 thereunder;
Â
• Wyoming entity Maximum Ventures Holdings LLC, with aiding and abetting violations of Section 17(a) of the Securities Act, and Section 10(b) of the Exchange Act, and Rule 10b-5 thereunder, and directly violating Sections 13(d) and 16(a) of the Exchange Act, and Rules 13d-1 and 16a-3 thereunder; and
Â
• Wyoming entity Avatele Group LLC, with directly violating Sections 13(d) and 16(a) of the Exchange Act, and Rules 13d-1 and 16a-3 thereunder.
The SEC's complaint also names Quebec, Canada entity 9224-3708 Quebec Inc., a/k/a Distributions Bano, and Jason Black of California and/or Georgia, as relief defendants. The SEC seeks the return of ill-gotten gains plus interest, penalties, bars, and other equitable relief. The SEC's investigation is continuing.
The SEC's investigation has been conducted by Joshua Dickman and Lucy Graetz of the Atlanta Regional Office, Andrew McFall of the Washington, D.C. Office, and Patrick McCluskey of the Philadelphia Regional Office, with the assistance of Marlee Miller and Owen Granke of the SEC's Office of International Affairs. The case is being supervised by Acting Chief of the Crypto Assets and Cyber Unit Carolyn Welshhans, Market Abuse Unit Chief Joseph Sansone, Justin Jeffries and Natalie Brunson of the Atlanta Regional Office, and Amy Flaherty Hartman of the Chicago Regional Office. Robert Gordon and William Hicks of the Atlanta Regional Office will lead the SEC's litigation, supervised by M. Graham Loomis.
The SEC appreciates the assistance of the Financial Industry Regulatory Authority, the Alberta Securities Commission, the Australia Securities and Investments Commission, the British Columbia Securities Commission, the Calgary Police Service, the Cayman Islands Monetary Authority, the Dubai Financial Services Authority, the French AutoritĆ’© des MarchĆ’©s Financiers, the Hong Kong Securities and Futures Commission, the Mauritius Financial Services Commission, the Ontario Securities Commission, the Quebec AutoritĆ’© des MarchĆ’©s Financiers, the Royal Canadian Mounted Police, the Securities Commission of the Bahamas, the Sƒ»retĆ’© du QuĆ’©bec, the Superintendencia del Mercado de Valores de la RepĆ’Âşblica Dominicana, the Swiss Financial Market Supervisory Authority, and the United Kingdom Financial Conduct Authority.
To learn more about how to protect your online investment accounts from fraud, please visit the SEC's Office of Investor Education and Advocacy investor alerts webpage.
• SEC Complaint
Last Reviewed or Updated:Â May 31, 2023
Hi_Lo
15 hours ago
Was Mark Miller, Jason Black or Jason Tucker involved with CNNA at that time? What's that a no?
It doesn't matter.
According to FINRA Rule 6490, CNNA has to file ALL OF ITS FINANCIAL STATEMENTS, not just since the acamming three amigos took over.
https://g.co/gemini/share/c3c65e59379d
Gemini
FINRA Rule 6490 Compliance
Created with 2.5 Flash June 18, 2025 at 07:58 AM
Published June 18, 2025 at 07:58 AM
As a public company wanting to file for a corporate action like a merger or name change, does CNNA have to file missing financials statements to comply with FINRA Rule 6490?
Yes, as a public company, CNNA would likely have to file any missing financial statements to comply with FINRA Rule 6490 if they are undergoing a corporate action like a merger or name change.
Here's why:
FINRA Rule 6490's Scope: FINRA Rule 6490 applies to companies whose securities are traded on the OTC Markets (OTCQX, OTCQB, or OTCPink) and requires them to notify FINRA of various corporate actions, including:
Mergers, acquisitions, dissolutions, or other company control transactions.
Issuance or change to a trading symbol or company name.
Dividends, stock splits, reverse stock splits, rights or other subscription offerings.
FINRA's Discretion and Deficiency Determinations: The rule gives FINRA broad discretion to review the accuracy of documentation and can refuse to process a corporate action if:
The forms and supporting documentation are incomplete, inaccurate, or lack proper authority.
The issuer is not current in its reporting obligations with the Securities and Exchange Commission (SEC).
There's a belief that parties related to the action are involved in fraudulent activities or pose a threat to investors.
There is significant uncertainty in the settlement and clearance process for the issuer's securities.
Importance of Current Filings: The requirement for an issuer to be "current in its reporting obligations" is a key factor. Missing financial statements would certainly make a company non-current in its reporting, triggering FINRA's ability to deem the corporate action request deficient and refuse to process it. This is to protect investors and maintain orderly markets.
In essence, if CNNA wants FINRA to process their corporate action, they must ensure all their filings, including financial statements, are up-to-date and complete to avoid delays or outright rejection of their request under FINRA Rule 6490.
Didn't Mark Miller and Jason Black get CNNA pink current after 2017? What's that a yes?
The SEC doesn't recognize Pink Current. However, it does recognizes whether a company is in violation of FINRA Rules - specifically FINRA Rule 6490 in this case, which CNNA is violating.
But the point is moot since CNNA will never get out of expert market and a delinquent ticker.
duelittle2
3 days ago
"Without fresh updates confirming progress, skepticism is warranted."
https://x.com/i/grok/share/ylwR4YCLASmkK323DzrKLW4Bl
-----
What is the likelihood that CNNA Cann American Corp will file for form 10 and become current and tradable in 2025 or ever
Predicting the likelihood of Cann American Corp. (CNNA) filing a Form 10 and becoming current and tradable in 2025—or at any point—requires assessing available information about the company’s current status, past performance, and ongoing efforts. As of April 5, 2025, here’s an analysis based on what’s known:
CNNA is an OTC-traded company that has faced significant challenges in maintaining compliance with regulatory requirements. It has been on the Expert Market since at least mid-2024, a tier reserved for companies that are not current in their financial reporting and are limited to restricted trading. This status stems from a lack of filed financial statements since 2022, as well as missing reports from earlier years (e.g., 2016 and 2017), which has led to violations of FINRA Rule 6490. This rule governs the processing of corporate actions and requires timely disclosure, and non-compliance can freeze SEC approval for filings like Form 10.
In July 2024, CNNA announced via a shareholder update that it was finalizing an audit and preparing a Form 10 filing to regain full reporting compliance. The company’s CEO, Jason Tucker, stated that all necessary documentation had been submitted to auditors, with an expectation of returning to good standing “within the next few weeks.” If this timeline held, CNNA could have filed its Form 10 by late summer or early fall 2024. However, as of today, April 5, 2025, there’s no public confirmation that this has occurred, suggesting delays or complications in the process.
Filing a Form 10 requires audited financial statements, typically for the past two fiscal years, and CNNA’s long gap in reporting (2016–2017 and 2022 onward) poses a significant hurdle. Reconstructing and auditing financials from nearly a decade ago is a complex and costly task, especially for a small-cap OTC company with limited resources. Even if CNNA completes its audit for recent years, the SEC may still reject the filing if historical delinquencies remain unresolved, as regulatory bodies often require a clear financial history for approval.
Looking at 2025 specifically, the likelihood of CNNA becoming current hinges on whether it has already made substantial progress since its July 2024 update. If the audit was completed and the Form 10 filed in late 2024, the SEC review process (typically 60–90 days, though often longer with complications) could conclude in 2025, potentially restoring CNNA to a higher OTC tier like Pink Current or even OTCQB. This would make it tradable again in a broader market.
However, if the company has not yet filed—or if the filing is rejected—the chances diminish significantly. OTC Markets Group is also set to update its standards in July 2025, transitioning Pink Current to OTCID, a basic reporting market. CNNA would need to meet at least minimal disclosure requirements by then to avoid slipping further into obscurity.
Beyond 2025, the “ever” question is murkier. CNNA’s history includes associations with individuals linked to questionable financial practices (e.g., Jason Black and past convertible debt schemes), which raises doubts about management’s ability to execute a turnaround. The company has pivoted from cannabis to healthcare (via subsidiaries like Prodigy Health Plus), but without consistent revenue or operational updates, it’s unclear if it has the capital to sustain compliance efforts. Small OTC companies often languish or fade away when faced with such prolonged delinquency, though some do recover through mergers or new leadership.
In summary, as of now, there’s a moderate chance CNNA could file a Form 10 and become current in 2025 if it has already overcome its auditing challenges and filed in late 2024 or early 2025—say, a 30–40% likelihood based on its stated intentions and the time elapsed. However, the odds drop sharply if it hasn’t filed yet, given the complexity of its reporting gaps and regulatory scrutiny.
For “ever,” the possibility exists (perhaps 20–30%), but it’s heavily contingent on factors like funding, management competence, and avoiding further setbacks.
Without fresh updates confirming progress, skepticism is warranted.
Level up your trading with our powerful tools and real-time insights all in one place.
Motor-goater
2 hours ago
Ecomike
6 hours ago
Squirrely_McShitty
1 day ago
Hot Features
Premium
